CC BY 4.0 · Journal of Digestive Endoscopy 2025; 16(01): 037-043
DOI: 10.1055/s-0045-1806741
Research Article

Endoscopic Cyanoacrylate Injection in the Management of Gastric Varices: Long-Term Safety and Efficacy

Anand Kumar Raghavendran
1   Department of Gastroenterology and Hepatology, Kasturba Hospital, Manipal Academy of Higher Education, Manipal, Karnataka, India
,
Shiran Shetty
1   Department of Gastroenterology and Hepatology, Kasturba Hospital, Manipal Academy of Higher Education, Manipal, Karnataka, India
,
Balaji Musunuri
1   Department of Gastroenterology and Hepatology, Kasturba Hospital, Manipal Academy of Higher Education, Manipal, Karnataka, India
,
1   Department of Gastroenterology and Hepatology, Kasturba Hospital, Manipal Academy of Higher Education, Manipal, Karnataka, India
,
Preety Kumari
1   Department of Gastroenterology and Hepatology, Kasturba Hospital, Manipal Academy of Higher Education, Manipal, Karnataka, India
,
Suriya Nedunchezhian
1   Department of Gastroenterology and Hepatology, Kasturba Hospital, Manipal Academy of Higher Education, Manipal, Karnataka, India
,
Athish Shetty
1   Department of Gastroenterology and Hepatology, Kasturba Hospital, Manipal Academy of Higher Education, Manipal, Karnataka, India
,
C. Ganesh Pai
1   Department of Gastroenterology and Hepatology, Kasturba Hospital, Manipal Academy of Higher Education, Manipal, Karnataka, India
,
1   Department of Gastroenterology and Hepatology, Kasturba Hospital, Manipal Academy of Higher Education, Manipal, Karnataka, India
› Author Affiliations
Funding None declared.

Abstract

Introduction

Despite endoscopic ultrasound-based endotherapy and radiologic intervention, endoscopic cyanoacrylate (E-CYA) injection still remain as commonly performed treatment modality for bleeding gastric varices (GVs) in real world. We analyzed the long-term safety and efficacy of E-CYA in bleeding GVs.

Patients and Methods

In this retrospective analysis, patients who underwent E-CYA for GVs over the past 10 years were analyzed. The technical success, hemostasis rate, rebleeding rate, mortality rate, and procedure-related complications were analyzed. The predictive factors for a rebleed in terms of Child–Pugh status, the type, form, and size of GVs were computed.

Results

Of the 113, 96 (84.9%) met the inclusion criteria. The median follow-up was 30 (12–49) months. The mean age was 48.1 ± 6.1 years with most being male (83.3%, n = 80). The majority of them had cirrhosis (85.4%, n = 82). The technical success to achieve primary hemostasis was 98.9%. The median volume of glue to achieve hemostasis for each session was 2 (2–4) mL. At 1 month, 12 patients had a clinically significant rebleed (12.5%) and 6 (6.3%) had a rebleed at 6 months. At 1 and 6 months, 68.75% did not require further glue injection. The disease-related mortality was 10.41%. There was no procedure-related mortality.

Conclusion

E-CYA injection shows excellent efficacy and long-term safety with low rebleeding rates and negligible procedure-related complications.

Ethical Approval and Consent to Participate

Taken from institutional ethical committee.


Consent for Publication

Sought from the patient.


Availability of Supporting Data

Available from G.B. upon reasonable request.


Authors' Contributions

A.K. and S.N.: Preparing the primary draft of the manuscript. P.K., A.S., and B.M.: Data collection. G.P.C., G.B., and S.S.: Review of the manuscript. S.R.: Statistical analysis.




Publication History

Article published online:
17 March 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16 (06) 1343-1349
  • 2 Kim T, Shijo H, Kokawa H. et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997; 25 (02) 307-312
  • 3 Henry Z, Patel K, Patton H, Saad W. AGA clinical practice update on management of bleeding gastric varices: expert review. Clin Gastroenterol Hepatol 2021; 19 (06) 1098-1107.e1
  • 4 Seewald S, Ang TL, Imazu H. et al. A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos). Gastrointest Endosc 2008; 68 (03) 447-454
  • 5 Samanta J, Nabi Z, Facciorusso A. et al. EUS-guided coil and glue injection versus endoscopic glue injection for gastric varices: international multicentre propensity-matched analysis. Liver Int 2023; 43 (08) 1783-1792
  • 6 Cheng LF, Wang ZQ, Li CZ, Lin W, Yeo AET, Jin B. Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate. Clin Gastroenterol Hepatol 2010; 8 (09) 760-766
  • 7 Desai PN, Patel CN, Kabrawala MV. et al. Use of cyanoacrylate glue in gastric variceal bleed: a modified technique without using lipiodol. VideoGIE 2021; 6 (04) 155-158
  • 8 Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K. Endoscopic classification of gastric varices. Gastrointest Endosc 1990; 36 (03) 276-280
  • 9 Rajoriya N, Forrest EH, Gray J. et al. Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding. QJM 2011; 104 (01) 41-47
  • 10 Kang EJ, Jeong SW, Jang JY. et al. Long-term result of endoscopic histoacryl (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices. World J Gastroenterol 2011; 17 (11) 1494-1500
  • 11 Choudhuri G, Chetri K, Bhat G. et al. Long-term efficacy and safety of N-butylcyanoacrylate in endoscopic treatment of gastric varices. Trop Gastroenterol 2010; 31 (03) 155-164
  • 12 Marques P, Maluf-Filho F, Kumar A, Matuguma SE, Sakai P, Ishioka S. Long-term outcomes of acute gastric variceal bleeding in 48 patients following treatment with cyanoacrylate. Dig Dis Sci 2008; 53 (02) 544-550
  • 13 Huang YH, Yeh HZ, Chen GH. et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc 2000; 52 (02) 160-167
  • 14 D'Imperio N, Piemontese A, Baroncini D. et al. Evaluation of undiluted N-butyl-2-cyanoacrylate in the endoscopic treatment of upper gastrointestinal tract varices. Endoscopy 1996; 28 (02) 239-243
  • 15 Mosli MH, Aljudaibi B, Almadi M, Marotta P. The safety and efficacy of gastric fundal variceal obliteration using N-butyl-2-cyanoacrylate; the experience of a single Canadian tertiary care centre. Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc 2013; 19 (04)
  • 16 Akahoshi T, Hashizume M, Shimabukuro R. et al. Long-term results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience. Surgery 2002; 131 (1, Suppl): S176-S181
  • 17 Joo HS, Jang JY, Eun SH. et al. Long-term results of endoscopic histoacryl (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices–a 10-year experience [in Korean]. Korean J Gastroenterol 2007; 49 (05) 320-326
  • 18 Guo YW, Miao HB, Wen ZF, Xuan JY, Zhou HX. Procedure-related complications in gastric variceal obturation with tissue glue. World J Gastroenterol 2017; 23 (43) 7746-7755
  • 19 Butt N, Haleem F, Khan MA, Abbasi A. Efficacy and safety of N-butyl 2 cyanoacrylate injection for treatment of gastric varices: a five year experience from a tertiary care hospital in Karachi, Pakistan. Pak J Med Sci 2022; 38 (05) 1360-1365
  • 20 Iqbal Janjua F, Ahmad M, Javed S. et al. Endoscopic therapy of gastric varices: safety and efficacy of N-butyl-2-cyanoacrylate injection. Cureus 2023; 15 (11) e49539
  • 21 Goral V, Yılmaz N. Current approaches to the treatment of gastric varices: glue, coil application, TIPS, and BRTO. Medicina (Kaunas) 2019; 55 (07) 335
  • 22 Albillos A, Ruiz del Arbol L. “Salvage” transjugular intrahepatic portosystemic shunt: gastric fundal compared with esophageal variceal bleeding. Gastrointest Endosc 1999; 50 (02) 294-295
  • 23 Matsumoto A, Hamamoto N, Nomura T. et al. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices. Am J Gastroenterol 1999; 94 (03) 643-649
  • 24 Stanley AJ, Jalan R, Ireland HM, Redhead DN, Bouchier IA, Hayes PC. A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther 1997; 11 (01) 171-176
  • 25 Lo GH, Liang HL, Chen WC. et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007; 39 (08) 679-685
  • 26 Fujii-Lau LL, Law R, Wong Kee Song LM, Gostout CJ, Kamath PS, Levy MJ. Endoscopic ultrasound (EUS)-guided coil injection therapy of esophagogastric and ectopic varices. Surg Endosc 2016; 30 (04) 1396-1404
  • 27 Jamwal KD, Padhan RK, Sharma A, Sharma MK. Endoscopic ultrasound-guided coiling and glue is safe and superior to endoscopic glue injection in gastric varices with severe liver disease: a retrospective case control study. Clin Endosc 2023; 56 (01) 65-74